Massivemarkets

SEC Form 4

Praxis Precision Medicines, Inc. (PRAX) insider trading

In the 12 months to Nov 19, 2026, 3 PRAX insiders reported open-market sales of $11.1M across 3 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$11.1M
3 filings · 3 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
1 of 3
$3.6M of $11.1M sold (33%)

Who traded PRAX, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

PRAX daily close from Nov 19, 2025 to Nov 18, 2026, between $164.09 and $386.33, last $305.19. 3 sale and 0 purchase filings by 3 insiders, marked at their filing dates. Alex Nemiroff, General Counsel and Secretary: sold $4.9M across 1 filing, first filed Nov 21, 2025, last Nov 21, 2025. Jill DeSimone, Director: sold $3.6M across 1 filing, first filed Jun 26, 2026, last Jun 26, 2026. Lauren Mastrocola, Principal Accounting Officer: sold $2.6M across 1 filing, first filed Nov 21, 2025, last Nov 21, 2025.

Largest mark · tap a row for others

Alex Nemiroff · General Counsel and Secretary

Sale $4,852,256

25,130 shares at $193.09 avg

Filed Nov 21, 2025 · traded Nov 20

Close on filing date $169.80

PRAX daily closelast $305.19

Alex Nemiroff · General Counsel and Secretary

$4.9M sold

Jill DeSimone · Director

$3.6M sold

Lauren Mastrocola · Principal Accounting Officer

$2.6M sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

3 filings in the last 12 months
Other insider activity (not market trades) · 57 records
  • Option exercises14 records
  • Tax withholding13 records
  • Grants and awards27 records
  • Gifts3 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Praxis Precision Medicines, Inc.'s CEO sold stock?

No. Marcio Souza (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is PRAX’s insider data?

These are PRAX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track PRAX insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for PRAX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.